FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1952655 · Received January 7, 2011

Report

Report Number
2124215-2010-23653
Event Type
Injury
Date Received
January 7, 2011
Date of Event
December 7, 2010
Report Date
December 7, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVISION WAS PERFORMED AND THIS RA LEAD WAS CAPPED AND SUCCESSFULLY REPLACED. NO ADDITIONAL INFORMATION IS AVAILABLE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT ATRIAL (RA) LEAD PRESENTED WITH PACING IMPEDANCE MEASUREMENTS ABOVE 3000 OHMS AND LOSS OF CAPTURE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention